Some 2-(4-bromophenoxymethyl)-6-iodo-3-substituted quinazolin-4(3H)ones: Synthesis, cytotoxic activity, EGFR inhibition and molecular docking

被引：2
|
作者：
Abbas, Safinaz E-S. [1 ]
Abdel-Gawad, Nagwa M. [1 ]
George, Riham F. [1 ]
Abu Elyazid, Mohamed G. [1 ]
Zaater, Marwa A. [1 ]
El-Ashrey, Mohamed K. [1 ,2 ]
机构：
[1] Cairo Univ, Dept Pharmaceut Chem, Fac Pharm, Cairo 11562, Egypt
[2] King Salman Int Univ, Fac Pharm, Dept Med Chem, Ras Sedr, South Sinai, Egypt
来源：
JOURNAL OF MOLECULAR STRUCTURE | 2022年 / 1269卷
关键词：
Quinazoline; EGFR; HCT116; MCF-7; A-549; Molecular docking; Molecular dynamics simulation; EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; BREAST-CANCER; CELL-DEATH; EXPRESSION; ADENOCARCINOMA; MUTATIONS;
D O I：
10.1016/j.molstruc.2022.133851
中图分类号：
O64 [物理化学（理论化学）、化学物理学];
学科分类号：
070304 ; 081704 ;
摘要：
Different 6-iodo-2-(4-bromophenyoxymethyl)-3-substituted quinazolin-4-ones were prepared and tested for their cytotoxic activity against MCF-7 (breast), A-549 (lung) and HCT-116 (colon) cancer cell lines as well as normal fibroblasts WI-38. They revealed promising activity specially against A-549 and HCT 116 compared to Erlotinib. Compounds eliciting high cytotoxicity were further tested for their EGFR inhibitory activity and it was found that compounds 8, 9, 11a, b revealed superior activity than Gefitinib. Molecular docking of these compounds at the active site of EGFR confirmed the obtained activity as they showed binding interactions with the key amino acids as that of co-crystallized ligand. Therefore, these compounds can be considered as a promising core for anticancer agents with EGFR inhibitory activity. (C) 2022 Elsevier B.V. All rights reserved.
引用
收藏
页数：13
相关论文
共 50 条
  • [31] Push-Pull Structures Based on 2-Aryl/thienyl Substituted Quinazolin-4(3H)-ones and 4-Cyanoquinazolines
    Moshkina, Tatyana N.
    Nosova, Emiliya, V
    Permyakova, Julia, V
    Lipunova, Galina N.
    Zhilina, Ekaterina F.
    Kim, Grigory A.
    Slepukhin, Pavel A.
    Charushin, Valery N.
    MOLECULES, 2022, 27 (21):
  • [32] 2-(Chloromethyl)-3-phenylquinazolin-4(3H)-ones as potent anticancer agents; cytotoxicity, molecular docking and in silico studies
    Emami, Leila
    Faghih, Zeinab
    Khabnadideh, Soghra
    Rezaei, Zahra
    Sabet, Razieh
    Harigh, Ebrahim
    Faghih, Zahra
    JOURNAL OF THE IRANIAN CHEMICAL SOCIETY, 2021, 18 (08) : 1877 - 1889
  • [33] Design, Synthesis, Pharmacological Evaluation of Quinazolin-4(3H)-Ones Bearing Urea Functionality as Potential VEGFR-2 Inhibitors
    Al-Sanea, Mohammad M.
    Hafez, Hani M.
    AB Mohamed, Ahmed
    El-Shafey, Hamed W.
    Elgazar, Abdullah A.
    Tawfik, Samar S.
    Ewes, Wafaa A.
    Hussein, Shaimaa
    Alsahli, Tariq G.
    Hamdi, Abdelrahman
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 5109 - 5127
  • [34] Ligand-based drug design of quinazolin-4(3H)-ones as breast cancer inhibitors using QSAR modeling, molecular docking, and pharmacological profiling
    Abdullahi, Sagiru Hamza
    Uzairu, Adamu
    Shallangwa, Gideon Adamu
    Uba, Sani
    Umar, Abdullahi Bello
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2023, 35 (01)
  • [35] Synthesis, in silico and in vitro antimicrobial efficacy of substituted arylidene-based quinazolin-4(3H)-one motifs
    Oduselu, Gbolahan O.
    Aderohunmu, Damilola V.
    Ajani, Olayinka O.
    Elebiju, Oluwadunni F.
    Ogunnupebi, Temitope A.
    Adebiyi, Ezekiel
    FRONTIERS IN CHEMISTRY, 2023, 11
  • [36] Ligand-based drug design of quinazolin-4(3H)-ones as breast cancer inhibitors using QSAR modeling, molecular docking, and pharmacological profiling
    Sagiru Hamza Abdullahi
    Adamu Uzairu
    Gideon Adamu Shallangwa
    Sani Uba
    Abdullahi Bello Umar
    Journal of the Egyptian National Cancer Institute, 35
  • [37] Synthesis, Antimicrobial Evaluation, Molecular Docking and Dynamics Simulations of Novel 2,3-Disubstituted Quinazolin-4(3H)-one Derivatives
    Verma, Priyanka
    Xiang, Lai Zhen
    Chaube, Udit
    Natesan, Gopal
    CHEMISTRYSELECT, 2024, 9 (36):
  • [38] Synthesis and biological evaluation of certain 3-substituted benzylideneamino-2-(4-nitrophenyl)quinazolin-4(3H)-one derivatives
    Alafeefy, Ahmed M.
    Awaad, Amani S.
    Abdel-Aziz, Hatem A.
    El-Meligy, Reham M.
    Zain, Mohamed E.
    Al-Outhman, Mounerah R.
    Bacha, Abir B.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2015, 30 (02) : 270 - 276
  • [39] Molecular docking study and antiviral evaluation of 2-thioxo-benzo[g]quinazolin-4(3H)-one derivatives
    Rashad Al-Salahi
    Hatem A. Abuelizz
    Hazem A. Ghabbour
    Rabab El-Dib
    Mohamed Marzouk
    Chemistry Central Journal, 10
  • [40] Synthesis of some novel quinazolin-4(3H)-one hybrid molecules as potent urease inhibitors
    Mentese, Emre
    Akyuz, Gulay
    Yilmaz, Fatih
    Baltas, Nimet
    Emirik, Mustafa
    ARCHIV DER PHARMAZIE, 2018, 351 (12)
12345